enVVeno Medical Corporation announced that Andrew Cormack has been hired as the Company's Chief Commercial Officer. Mr. Cormack, who joined enVVeno Medical on April 8, comes to enVVeno following a career at both start-up and large medical device companies including WallabyPhenox, Medtronic, Covidien, and ev3. Mr. Cormack has held numerous regional, national, and international sales and marketing positions throughout his almost 25-year career in med-tech and holds a Bachelor of Arts degree in Kinesiology from The University of Western Ontario, where he graduated with honors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.93 USD | -0.40% | -1.40% | -4.09% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.09% | 65.98M | |
+64.92% | 62.59B | |
-1.85% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+13.05% | 26.21B | |
-21.96% | 19.09B | |
+4.21% | 13.08B | |
+25.74% | 12.26B | |
+27.42% | 12.05B |
- Stock Market
- Equities
- NVNO Stock
- News enVVeno Medical Corporation
- EnVVeno Medical Corporation Appoints Andrew Cormack as Its Chief Commercial Officer